StockNews.AI
UTHR
StockNews.AI
14 days

United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program

1. UTHR announces $1 billion share repurchase agreement with Citibank, boosting shareholder value.

Shares Buyback
+7.13%Current Return
VS
-1.64%S&P 500
$274.708/01 07:17 AM EDTEvent Start
$294.2808/04 07:27 AM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

Share repurchase programs typically signal confidence in the company's value, leading to stock price appreciation. Previous ASR programs have historically improved share prices for UTHR and similar companies.

How important is it?

A $1 billion ASR indicates strong leadership confidence and represents significant capital efficiency, thus dramatically influencing UTHR's stock perception and market dynamics.

Why Short Term?

The immediate effect of share repurchases can boost stock price quickly, often seen within weeks. Historical examples indicate stock prices react favorably shortly after such announcements.

Related Companies

CITI
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced that it will enter today into two Accelerated Share Repurchase (ASR) agreements with Citibank, N.A. (Citi) to repurchase an aggregate $1 billion of UTHR common stock. United Therapeutics will repurchase these shares under the $1 billion repurchase program authorized by the company's board of directors and previously announced on July 30, 202.

Related News